Prognostic Impact of Pre-transplant Computed Tomography And Gallium Scan in Chemosensitive Diffuse Large Cell Lymphoma Patients Undergoing Hematopoietic Stem-Cell Transplantation Escobar IG, Alonso PT, Barrigón DC, Pérez-Simón JA, Mateos Manteca MV, San Miguel JF. Annals of Nuclear Medicine 22(4):251-60. FI: 0.917 (Q4) Zalypsis: A novel marine compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double strand breaks Ocio EM, Maiso P, Chen X, Garayoa M, Álvarez-Fernández S, San-Segundo L, Vilanova D, López-Corral L, Montero JC, Hernández-Iglesias T, De Álava E, Galmarini C, Avilés P, Cuevas C, San Miguel JF, Pandiella A. Blood 16:113(16):3781-91. FI: 10.550 (Q1) Multiparameter flow cytometry remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation Paiva B, Vidriales MB, Cervero J, Mateo G, Pérez JJ, Montalbán MA, Sureda A, Montejano L, Gutiérrez NC, García de Coca A, de Las Heras N, Mateos MV, López-Berges MC, García-Boyero R, Galende J, Hernández J, Palomera L, Carrera D, Martínez R, de la Rubia J, Martín A, Blade J, Lahuerta JJ, Orfao A, San Miguel JF. Blood 112(10):4017-23. FI: 10.555 (Q1) R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome Martín A, Caballero D, Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea. Haematologica 94(5):744. FI: 6.416 (Q1) Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin¿s lymphoma: identification of prognostic factors predicting outcome Robinson SP, Sureda A, Canals C, Russell N, Caballero D, Bacigalupo A, Iriondo A, Cook G, Pettitt A, Socie G, Bonifazi F, Bosi A, Michallet M, Liakopoulou E, Maertens J, Passweg J, Clarke F, Martino R, Schmitz N, Lymphoma Working Party of the EBMT. Haematologica 94(2):230-8. FI: 6.416 (Q1) Implications of the European Organisation for Research and Treatment of Cancer (EORTC) guidelines on the use of granulocyte colony-stimulating factor (G-CSF) for lymphoma care Pettengell R, Aapro M, Brusamolino E, Caballero D, Coiffier B, Pfreundschuh M, Trneny M, Walewski. Clinical Drug Investigation 29(8):491-513. FI: 1.414 (Q3) Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study Gallardo D, de la Cámara R, Nieto JB, Espigado I, Iriondo A, Jiménez-Velasco A, Vallejo C, Martín C, Caballero D, Brunet S, Serrano D, Solano C, Ribera JM, de la Rubia J, Carreras E. Haematologica 94(9):1282-8. FI: 6.416 (Q1) Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects Sánchez-Guijo FM, Blanco JF, Cruz G, Muntión S, Gómez M, Carrancio S, López-Villar O, Barbado MV, Sánchez-Abarca LI, Blanco B, Briñón JG, del Cañizo MC. Cell and Tissue Research 336(3):501-7. FI: 2.308 (Q3) Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas Robledo C, García JL, Caballero D, Conde E, Arranz R, Flores T, Grande C, Rodríguez J, García E, Sáez AI, González M, Gutiérrez NC, Piris MA, Hernández JM, Spanish Lymphoma/ Autologous Bone Marrow Transplant Study Group(GEL-TAMO). Cancer 115(16):3728-37. FI: 5.418 (Q1) Oral beclomethasone dipropionate for the treatment of gastrointestinal chronic graft-versus-host disease Villanueva FN, Pérez-Simón JA, Silva FF, Caballero-Velázquez TT, Sánchez-Guijo FF, Cañizo CC, Vázquez L, Caballero DD, San Miguel JF. Biology of Blood and Marrow 15(10):1331-6. FI: 3.149 (Q2)
|
